Latest

Neurology

·August 8, 2024·8 min read

Light and Sound Therapy Maintains Myelin in Alzheimer’s

A new study finds that 40Hz light and sound therapy helps maintain myelin, a crucial brain structure, in Alzheimer's patients. This therapy, which protects neurons and supports brain function, could offer new treatment avenues for neurodegenerative diseases. Researchers discovered that this stimulation enhances neural connections and reduces harmful inflammation. The therapy also shows potential for treating other conditions involving myelin loss, such as multiple sclerosis.

Featured Neurology Neuroscience

·August 6, 2024·5 min read

Dopamine Treatment Reduces Alzheimer’s Plaques

Researchers uncovered a promising approach to treating Alzheimer’s disease by using dopamine to enhance brain enzyme activity that reduces harmful plaques. Conducted on mice, the study shows that dopamine increases neprilysin production, which breaks down beta-amyloid plaques linked to Alzheimer's.

This shows a brain surrounded by seaweed.

Featured Neurology Neuroscience

·August 5, 2024·3 min read

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Researchers have found that antioxidants from Ecklonia cava, a type of seaweed, may help prevent Parkinson's disease by protecting dopamine-producing neurons. In mouse models, these antioxidants restored motor function and improved gut health after exposure to toxins. Cellular studies revealed that these compounds activate the AMPK enzyme and reduce harmful reactive oxygen species, potentially offering a new approach to combat neurodegeneration. This discovery highlights the potential of Ecklonia cava as a preventive ingredient against Parkinson's disease.

Featured Genetics Neurology Neuroscience

·August 5, 2024·5 min read

Genetically Engineered Parasite Delivers Drugs to the Brain

Researchers genetically engineered the parasite Toxoplasma gondii to deliver drugs across the blood-brain barrier. This innovative approach has been used to deliver therapeutic proteins to neurons, showing promise for treating neurological conditions like Rett syndrome. The research highlights the potential for parasites to act as delivery vehicles for large molecules that typically struggle to penetrate the brain. This breakthrough could lead to new treatments for a variety of neurological disorders.

Featured Neurology Neuroscience

·August 5, 2024·7 min read

New Multiple Sclerosis Drug Regenerates Myelin, Improves Movement

A new drug, PIPE-307, shows promise in reversing multiple sclerosis (MS) damage by promoting myelin regeneration around nerve cells, potentially restoring movement and function. Developed by researchers, this innovative therapy targets a specific receptor, M1R, and has already demonstrated success in animal models. PIPE-307 is currently in Phase II clinical trials, offering hope for a groundbreaking treatment that could stop and even heal the damage caused by MS. This novel approach could transform the future of MS therapy by addressing both symptoms and underlying damage.

Featured Genetics Neurology Neuroscience

·August 5, 2024·4 min read

Brain’s Defense Mechanism Against Herpesvirus Identified

Researchers have identified a novel defense mechanism in the brain that prevents herpesvirus from causing severe brain infections, despite the virus being present in over half the population. This discovery highlights the protective role of the TMEFF1 gene, which produces a protein that blocks the virus from entering nerve cells. The findings could lead to a better understanding of brain immunity and its role in preventing neurodegenerative diseases like Alzheimer's. This groundbreaking research opens new avenues for studying brain defense mechanisms and their implications for brain health.

Featured Genetics Neurology Neuroscience

·August 1, 2024·8 min read

Skin Cells Turned Neurons Reveal Alzheimer’s Aging Effects

Researchers have developed a method to transform skin cells into brain neurons, capturing the aging effects crucial for studying late-onset Alzheimer's disease. This technique accurately mimics Alzheimer's hallmarks, like amyloid beta buildup, in lab-derived neurons, allowing for detailed analysis.

This shows a child playing with her grandpa.

Featured Neurology Neuroscience

·July 31, 2024·9 min read

Intervention From Childhood Reduces Dementia Risks

A new report highlights that addressing 14 modifiable risk factors from childhood could prevent or delay nearly half of dementia cases. The study identifies high LDL cholesterol and untreated vision loss as new significant risks. Implementing early interventions can improve cognitive health and reduce the burden of dementia globally. Researchers emphasize the importance of targeted policies and lifestyle changes to mitigate these risks.

Featured Genetics Neurology

·July 30, 2024·5 min read

Genetic Factors Linked to Rare ALS Recovery

A new study reveals that certain genetic factors may protect against ALS, enabling partial or full recovery. Researchers found that a specific genetic variation reduces a protein blocking the IGF-1 pathway, which is crucial for motor neuron protection. This discovery provides a potential new approach for ALS treatment. The findings highlight the importance of further studying the IGF-1 pathway in ALS therapy.

Featured Neurology Neuroscience

·July 30, 2024·6 min read

Brain Blood Vessels Key to Combating Cognitive Decline

New research highlights the critical role of healthy blood vessels in maintaining brain health and addressing age-related cognitive decline. The study reveals that vascular degradation in the brain can lead to neurodegenerative disorders like Alzheimer's disease.

Featured Neurology Neuroscience

·July 30, 2024·6 min read

MRI Scan Predicts Alzheimer’s Risk Before Symptoms Appear

A novel study finds that specialized MRI scans can detect early brain changes that indicate a higher risk for Alzheimer’s disease (AD) before significant cognitive decline occurs. Researchers discovered that cortical microstructural changes in the brain closely resemble patterns seen in AD pathology.

Featured Neurology Neuroscience

·July 30, 2024·4 min read

GLP-1 Drug Slows Alzheimer’s Cognitive Decline

A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimer’s disease, slowing cognitive decline by 18% over one year. This effect is likely due to the drug’s ability to reduce brain inflammation, improve insulin resistance, and lower the impact of Alzheimer’s biomarkers.

1 … 52 53 54 55 56 … 603

Neurology

Light and Sound Therapy Maintains Myelin in Alzheimer’s

Dopamine Treatment Reduces Alzheimer’s Plaques

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Genetically Engineered Parasite Delivers Drugs to the Brain

New Multiple Sclerosis Drug Regenerates Myelin, Improves Movement

Brain’s Defense Mechanism Against Herpesvirus Identified

Skin Cells Turned Neurons Reveal Alzheimer’s Aging Effects

Intervention From Childhood Reduces Dementia Risks

Genetic Factors Linked to Rare ALS Recovery

Brain Blood Vessels Key to Combating Cognitive Decline

MRI Scan Predicts Alzheimer’s Risk Before Symptoms Appear

GLP-1 Drug Slows Alzheimer’s Cognitive Decline

Noninvasive Stimulation “Talks” to the Brain’s Memory Center

Neurons Lose Their “Adaptability” in Old Age

Suckers for Love: Octopus Arms “Tastes” for a Mate

Plug-and-Play Sensor Listens to the Developing Brain

Subscribe